International Journal of Clinical Science and Medical Research

Rectal cancer is a common and serious disease. Early diagnosis of rectal cancer can improve the effectiveness of treatment and the prognosis of the disease. Modern medical technology not only provides doctors with a series of methods to diagnose rectal cancer, but also brings more and more new means. This is a very exciting area of research, and many scientists and doctors are pushing the boundaries of knowledge and working to develop real, tangible inventions and techniques that can improve clinical outcomes for patients. We hope that by providing an indepth analysis of the current and potential future impact of these emerging technologies on rectal cancer detection, the article will serve to inform both the scientific community and the public about the revolutionary leaps forward that are being made in this area. These technologies, as well as the new diagnostic and therapeutic approaches that they facilitate, have the potential not only to greatly improve the management and outcome of rectal cancer, but also to substantially enhance the patient experience and indeed reshape the entire patient journey. The future directions and implications of these new technologies will also be explored, including their potential of changing the outcomes of rectal cancer, the ethical consideration in their implementation, as well as the challenges and barriers to their wide adoption.

Rectal, Cancer, Detection, Technologies, Methods, Malignant

1. Vogel JD, Felder SI, Bhama AR, Hawkins AT, Langenfeld SJ, Shaffer VO, Thorsen AJ, Weiser MR, Chang GJ, Lightner AL, Feingold DL. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer. Diseases of the Colon & Rectum. 2022 Feb 1;65(2):14877.fascrs.org
2. Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC. Vital signs: colorectal cancer screening test use—United States, 2018. Morbidity and Mortality Weekly Report. 2020 Mar 3;69(10):253.nih.gov
3. Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ. Trends in incidence of earlyonset colorectal cancer in the United States among those approaching screening age. JAMA network open. 2020 Jan 3;3(1):e1920407.jamanetwork.com
4. Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. Jama. 2021.HTML
5. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Translational oncology. 2021.sciencedirect.com
6. Stoffel EM, Murphy CC. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology. 2020.nih.gov
7. Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of adenocarcinoma and carcinoid tumors to earlyonset colorectal cancer incidence rates in the United States. Annals of internal medicine. 2021 Feb;174(2):15766.HTML
8. Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, Gad M, AlHusseini M, Saad A. Colorectal cancer epidemiology: recent trends and impact on outcomes. Current drug targets. 2021 Jul 1;22(9):9981009.HTML
9. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA: a cancer journal for clinicians. 2020 May;70(3):14564. wiley.com
10. You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, Paquette IM, Steele SR, Feingold DL. The American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer. Diseases of the Colon & Rectum. 2020 Sep 1;63(9):1191222.fascrs.org
11. Nagtegaal ID, GlynneJones R. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer treatment reviews. 2020.sciencedirect.com
12. Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nature Reviews Gastroenterology & Hepatology. 2020 Jul;17(7):41429.ucl.ac.uk
13. Lord AC, Knijn N, Brown G, Nagtegaal ID. Pathways of spread in rectal cancer: a reappraisal of the true routes to distant metastatic disease. European Journal of Cancer. 2020.sciencedirect.com
14. Wilkinson N. Management of rectal cancer. Surgical Clinics. 2020.HTML
15. Detering R, Rutgers ML, Bemelman WA, Hompes R, Tanis PJ. Prognostic importance of circumferential resection margin in the era of evolving surgical and multidisciplinary treatment of rectal cancer: A systematic review and metaanalysis. Surgery. 2021 Aug 1;170(2):41231.sciencedirect.com
16. Liu Z, Meng X, Zhang H, Li Z, Liu J, Sun K, Meng Y, Dai W, Xie P, Ding Y, Wang M. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nature communications. 2020 Aug 27;11(1):4308.nature.com
17. Lord AC, D’Souza N, Shaw A, Rokan Z, Moran B, Abulafi M, Rasheed S, Chandramohan A, Corr A, Chau I, Brown G. MRIdiagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Annals of surgery. 2022 Aug 28;276(2):33444.HTML
18. Kim TH, Firat C, Thompson HM, Gangai N, Zheng J, Capanu M, Bates DD, Paroder V, GarcíaAguilar J, Shia J, Gollub MJ. Extramural venous invasion and tumor deposit at diffusionweighted MRI in patients after neoadjuvant treatment for rectal cancer. Radiology. 2023 Aug 15;308(2):e230079.rsna.org
19. Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, Tao Q, Xu H. Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target. Molecular cancer. 2022 Jul 14;21(1):144.springer.com
20. O’Sullivan NJ, Temperley HC, Horan MT, Corr A, Mehigan BJ, Larkin JO, McCormick PH, Kavanagh DO, Meaney JF, Kelly ME. Radiogenomics: Contemporary Applications in the Management of Rectal Cancer. Cancers. 2023 Dec 12;15(24):5816.mdpi.com
21. Badic B, Tixier F, Cheze Le Rest C, Hatt M et al. Radiogenomics in colorectal cancer. Cancers. 2021.mdpi.com
22. O'Sullivan NJ, Kelly ME. Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions. Current Oncology. 2023.mdpi.com
23. O’Shea A, Harisinghani MG. Update on MRI of Rectal Cancer. Advances in Clinical Radiology. 2021 Sep 1;3:13.HTML
24. Shui L, Ren H, Yang X, Li J, Chen Z, Yi C, Zhu H, Shui P. The era of radiogenomics in precision medicine: an emerging approach to support diagnosis, treatment decisions, and prognostication in oncology. Frontiers in Oncology. 2021 Jan 26;10:570465. frontiersin.org
25. Bordron A, Rio E, Badic B, Miranda O, Pradier O, Hatt M, Visvikis D, Lucia F, Schick U, Bourbonne V. External validation of a radiomics model for the prediction of complete response to neoadjuvant chemoradiotherapy in rectal cancer. Cancers. 2022 Feb 21;14(4):1079.mdpi.com
26. Miranda J, Horvat N, AraujoFilho JA, Albuquerque KS, Charbel C, Trindade BM, Cardoso DL, de Padua Gomes de Farias L, Chakraborty J, Nomura CH. The Role of Radiomics in Rectal Cancer. Journal of Gastrointestinal Cancer. 2023 May 8:123.HTML
27. Wang Y, Ma LY, Yin XP, Gao BL. Radiomics and Radiogenomics in evaluation of colorectal cancer liver metastasis. Frontiers in Oncology. 2022. frontiersin.org
28. Katabathina VS, Marji H, Khanna L, Ramani N, Yedururi S, Dasyam A, Menias CO, Prasad SR. Decoding genes: Current update on radiogenomics of select abdominal malignancies. RadioGraphics. 2020 Oct;40(6):160026.rsna.org
29. Moussa AM, Ziv E. Radiogenomics in interventional oncology. Current Oncology Reports. 2021.HTML
30. Ciuti G, SkoniecznaŻydecka K, Marlicz W, Iacovacci V, Liu H, Stoyanov D, Arezzo A, Chiurazzi M, Toth E, Thorlacius H, Dario P. Frontiers of robotic colonoscopy: a comprehensive review of robotic colonoscopes and technologies. Journal of clinical medicine. 2020 May 31;9(6):1648.mdpi.com
31. OrtegaMorán JF, Azpeitia Á, SánchezPeralta LF, BoteCuriel L, Pagador B, Cabezón V, Saratxaga CL, SánchezMargallo FM. Medical needs related to the endoscopic technology and colonoscopy for colorectal cancer diagnosis. BMC cancer. 2021 Dec;21(1):12. biomedcentral.com
32. van Keulen KE, Jansen ME, Schrauwen RW, Kolkman JJ, Siersema PD. Volatile organic compounds in breath can serve as a non‐invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. Alimentary pharmacology & therapeutics. 2020 Feb;51(3):33446. wiley.com
33. Găină MA, Szalontay AS, Ștefănescu G, Bălan GG, Ghiciuc CM, Boloș A, Găină AM, Ștefănescu C. Stateoftheart review on immersive virtual reality interventions for colonoscopyinduced anxiety and pain. Journal of Clinical Medicine. 2022 Mar 17;11(6):1670.mdpi.com
34. Virarkar MK, Vulasala SS, Gupta AV, Gopireddy D, Kumar S, Hernandez M, Lall C, Bhosale P. Virtual noncontrast imaging in the abdomen and the pelvis: an overview. InSeminars in Ultrasound, CT and MRI 2022 Aug 1 (Vol. 43, No. 4, pp. 293310). WB Saunders.HTML
35. Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Artificial intelligence in colorectal cancer screening, diagnosis and treatment. A new era. Current Oncology. 2021 Apr 23;28(3):1581607. mdpi.com
36. Young EJ, Rajandran A, Philpott HL, Sathananthan D, Hoile SF, Singh R. Mucosal imaging in colon polyps: New advances and what the future may hold. World Journal of Gastroenterology. 2022 Dec 12;28(47):6632.nih.gov
37. Lorenzovici N, Dulf EH, Mocan T, Mocan L. Artificial intelligence in colorectal cancer diagnosis using clinical data: noninvasive approach. Diagnostics. 2021.mdpi.com
38. Robertson AR, Segui S, Wenzek… H. Artificial intelligence for the detection of polyps or cancer with colon capsule endoscopy. Therapeutic …. 2021. sagepub.com
39. Saraiva MM, Ferreira JP, Cardoso H, Afonso J, Ribeiro T, Andrade P, Parente MP, Jorge RN, Macedo G. Artificial intelligence and colon capsule endoscopy: development of an automated diagnostic system of protruding lesions in colon capsule endoscopy. Techniques in Coloproctology. 2021 Nov;25:12438.HTML
40. Wang PP, Deng CL, Wu B. Magnetic resonance imagingbased artificial intelligence model in rectal cancer. World Journal of Gastroenterology. 2021.nih.gov
41. Wong C, Fu Y, Li M, Mu S, Chu X, Fu J, Lin C, Zhang H. MRI‐Based Artificial Intelligence in Rectal Cancer. Journal of Magnetic Resonance Imaging. 2023 Jan;57(1):4556.HTML
42. Wang KS, Yu G, Xu C, Meng XH, Zhou J, Zheng C, Deng Z, Shang L, Liu R, Su S, Zhou X. Accurate diagnosis of colorectal cancer based on histopathology images using artificial intelligence. BMC medicine. 2021 Dec;19:12.springer.com
43. Rompianesi G, Pegoraro F, Ceresa CD, Montalti R, Troisi RI. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases. World Journal of Gastroenterology. 2022 Jan 1;28(1):108.nih.gov
44. Liu S, Zhang Y, Ju Y, Li Y, Kang X, Yang X, Niu T, Xing X, Lu Y. Establishment and clinical application of an artificial intelligence diagnostic platform for identifying rectal cancer tumor budding. Frontiers in Oncology. 2021 Mar 8;11:626626.frontiersin.org
45. Wang Y, He X, Nie H, Zhou J, Cao P, Ou C. Application of artificial intelligence to the diagnosis and therapy of colorectal cancer. American journal of cancer research. 2020;10(11):3575.nih.gov
46. Yin Z, Yao C, Zhang L, Qi S. Application of artificial intelligence in diagnosis and treatment of colorectal cancer: A novel Prospect. Frontiers in Medicine. 2023.frontiersin.org
47. Hamabe A, Ishii M, Kamoda R, Sasuga S, Okuya K, Okita K, Akizuki E, Sato Y, Miura R, Onodera K, Hatakenaka M. Artificial intelligence–based technology for semiautomated segmentation of rectal cancer using highresolution MRI. PLoS One. 2022 Jun 17;17(6):e0269931.plos.org
48. Hassan C, Spadaccini M, Mori Y, Foroutan F, Facciorusso A, Gkolfakis P, Tziatzios G, Triantafyllou K, Antonelli G, Khalaf K, Rizkala T. Realtime computeraided detection of colorectal neoplasia during colonoscopy: a systematic review and metaanalysis. Annals of Internal Medicine. 2023 Sep;176(9):120920.HTML
49. Chan SCH, Liang JQ. Advances in tests for colorectal cancer screening and diagnosis. Expert review of molecular diagnostics. 2022.researchgate.net
50. Maida M, Marasco G, Facciorusso A, Shahini E, Sinagra E, Pallio S, Ramai D, Murino A. Effectiveness and application of artificial intelligence for endoscopic screening of colorectal cancer: the future is now. Expert Review of Anticancer Therapy. 2023 Jul 3(justaccepted).researchgate.net
51. Mohammad MA, Abdelwahed SR, Eid KA, Mostafa HM. Comprehensive study between conventional colonoscopy and virtual CT colonography in assessment of colonic disorders. International Journal of Advanced Research in Medicine. 2023;5(2):12633.medicinepaper.net
52. Hissong E, Pittman ME. Colorectal carcinoma screening: Established methods and emerging technology. Critical Reviews in Clinical Laboratory Sciences. 2020 Jan 2;57(1):2236.HTML
53. Shah S, Park N, Chehade NE, Chahine A, Monachese M, Tiritilli A, Moosvi Z, Ortizo R, Samarasena J. Effect of computer‐aided colonoscopy on adenoma miss rates and polyp detection: a systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 2023 Feb;38(2):16276.HTML
54. Viscaino M, Bustos JT, Muñoz P, Cheein CA, Cheein FA. Artificial intelligence for the early detection of colorectal cancer: A comprehensive review of its advantages and misconceptions. World Journal of Gastroenterology. 2021 Oct 10;27(38):6399.nih.gov
55. Kaminski MF, Robertson DJ, Senore C, Rex DK. Optimizing the quality of colorectal cancer screening worldwide. Gastroenterology. 2020.gastrojournal.org
56. Hassan C, Spadaccini M, Iannone A, Maselli R, Jovani M, Chandrasekar VT, Antonelli G, Yu H, Areia M, DinisRibeiro M, Bhandari P. Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and metaanalysis. Gastrointestinal endoscopy. 2021 Jan 1;93(1):7785. iupui.edu
57. Crimi F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, Cecchin D. [18F] FDG PET/MRI in rectal cancer. Annals of Nuclear Medicine. 2021 Mar;35:28190.springer.com
58. Catalano OA, Lee SI, Parente C, Cauley C, Furtado FS, Striar R, Soricelli A, Salvatore M, Li Y, Umutlu L, Cañamaque LG. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging. 2021 Apr;48:123545.researchgate.net
59. Li Y, Mueller LI, Neuhaus JP, Bertram S, Schaarschmidt BM, Demircioglu A, Ludwig JM, Kirchner J, Rischpler C, Herrmann K, Catalano OA. 18FFDG PET/MR versus MR alone in wholebody primary staging and restaging of patients with rectal cancer: what is the benefit of PET?. Journal of Clinical Medicine. 2020 Sep 29;9(10):3163.mdpi.com
60. Schurink NW, Min LA, Berbee M, van Elmpt W, van Griethuysen JJ, Bakers FC, Roberti S, van Kranen SR, Lahaye MJ, Maas M, Beets GL. Value of combined multiparametric MRI and FDGPET/CT to identify wellresponding rectal cancer patients before the start of neoadjuvant chemoradiation. European radiology. 2020 May;30:294554.maastrichtuniversity.nl
61. Maffione AM, Montesi G, Caroli P, Colletti PM, Rubello D, Matteucci F. Is it time to introduce PET/CT in rectal cancer guidelines?. Clinical Nuclear Medicine. 2020 Aug 1;45(8):6117.HTML
62. Schurink NW, van Kranen SR, Berbee M, van Elmpt W, Bakers FC, Roberti S, van Griethuysen JJ, Min LA, Lahaye MJ, Maas M, Beets GL. Studying local tumour heterogeneity on MRI and FDGPET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer. European Radiology. 2021 Sep 1:18. maastrichtuniversity.nl
63. Yoon JH, Lee JM, Chang W, Kang HJ, Bandos A, Lim HJ, Kang SY, Kang KW, Ryoo SB, Jeong SY, Park KJ. Initial M staging of rectal cancer: FDG PET/MRI with a hepatocytespecific contrast agent versus contrastenhanced CT. Radiology. 2020 Feb;294(2):3109.rsna.org
64. Fernando S, Lin M, Pham TT, Chong S, Ip E, Wong K, Chua W, Ng W, Lin P, Lim S. Prognostic utility of serial 18FFDGPET/CT in patients with locally advanced rectal cancer who underwent trimodality treatment. The British Journal of Radiology. 2020 Jan;93(1105):20190455.nih.gov
65. Crimì F, Spolverato G, Lacognata C, Garieri M, Cecchin D, Urso ED, Zucchetta P, Pucciarelli S, Pomerri F. 18FFDG PET/MRI for rectal cancer TNM restaging after preoperative chemoradiotherapy: initial experience. Diseases of the Colon & Rectum. 2020 Mar 1;63(3):3108.HTML
66. Queiroz MA, Ortega CD, Ferreira FR, Nahas SC, Cerri GG, Buchpiguel CA. Diagnostic accuracy of FDGPET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients. European journal of nuclear medicine and molecular imaging. 2021 Jan;48:18695.HTML
67. Kotecha S, Vasudevan A, Holla VK, Kumar S, Pruthviraja D, Latte MV. 3D visualization cloud based model to detect and classify the polyps according to their sizes for CT colonography. Journal of King Saud UniversityComputer and Information Sciences. 2022 Sep 1;34(8):494355.sciencedirect.com
68. Raju AS, Jayavel K, Rajalakshmi T. Intelligent recognition of colorectal cancer combining application of computerassisted diagnosis with deep learning approaches. International Journal of Electrical and Computer Engineering. 2022 Feb 1;12(1):738. academia.edu
69. GarcíaFigueiras R, BaleatoGonzález S, CanedoAntelo M, Alcalá L, Marhuenda A. Imaging advances on ct and MRI in colorectal cancer. Current Colorectal Cancer Reports. 2021 Dec;17:11330.HTML
70. Rasouli P, Moghadam AD, Eslami P, Pasha MA, Aghdaei HA, Mehrvar A, NezamiAsl A, Iravani S, Sadeghi A, Zali MR. The role of artificial intelligence in colon polyps detection. Gastroenterology and Hepatology from Bed to Bench. 2020;13(3):191.nih.gov
71. Nimako AA. Is Conventional Colonoscopy More Effective Than Computed Tomography Colonography in the Screening of Colorectal Cancer Among Young African American …. 2023.acu.edu
72. Kadari M, Subhan M, Parel NS, Krishna PV, Gupta A, Uthayaseelan K, Uthayaseelan K, Sunkara NA. CT colonography and colorectal carcinoma: current trends and emerging developments. Cureus. 2022 May 11;14(5).cureus.com
73. Tamang LD, Kim BW. Deep learning approaches to colorectal cancer diagnosis: a review. Applied Sciences. 2021.mdpi.com
74. Tharwat M, Sakr NA, ElSappagh S, Soliman H, Kwak KS, Elmogy M. Colon cancer diagnosis based on machine learning and deep learning: Modalities and analysis techniques. Sensors. 2022 Nov 28;22(23):9250.mdpi.com
75. Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nature Reviews Gastroenterology & Hepatology. 2022.nature.com
76. Doubeni C. Tests for screening for colorectal cancer. UpToDate. Retrieved December. 2020.medilib.ir
77. Chiang TH, Lee YC. Options of Colorectal Cancer Screening: An Overview. Colorectal Cancer Screening: Theory and Practical Application. 2021:2940.HTML
78. Ferlizza E, Solmi R, Sgarzi M, Ricciardiello L, Lauriola M. The roadmap of colorectal cancer screening. Cancers. 2021 Mar 4;13(5):1101.mdpi.com
79. Emile SH, Barsom SH, Wexner SD. An updated review of the methods, guidelines of, and controversies on screening for colorectal cancer. The American Journal of Surgery. 2022.HTML
80. Bhattacharya S, Maru S, Setia A. Screening for Colorectal Carcinoma. Colorectal Cancer Diagnosis and Therapeutic Updates. 2022 Jun 1:8.HTML
81. Anipindi M, Doreswamy S, Ali R, Jilani A, Bitetto D. Colorectal Cancer Screening History, Methods and Future Perspectives. Archives of Clinical and Medical Case Reports. 2023;7:21639.fortuneonline.org
82. Smith RA, Fedewa S, Siegel R. Early colorectal cancer detection—Current and evolving challenges in evidence, guidelines, policy, and practices. Advances in cancer research. 2021.HTML
83. Nee J, Chippendale RZ, Feuerstein JD. Screening for colon cancer in older adults: risks, benefits, and when to stop. Mayo Clinic Proceedings. 2020. mayoclinicproceedings.org
84. Watanabe K, Nakamura Y, Low SK. Clinical implementation and current advancement of blood liquid biopsy in cancer. Journal of Human Genetics. 2021.HTML
85. Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: Current technology and clinical applications. Journal of Hematology & Oncology. 2022 Dec;15(1):14. biomedcentral.com
86. Soda N, Clack K, Shiddiky MJA. Recent advances in liquid biopsy technologies for cancer biomarker detection. Sensors & Diagnostics. 2022.rsc.org
87. Feng J, Li B, Ying J, Pan W, Liu C, Luo T, Lin H, Zheng L. Liquid biopsy: application in early diagnosis and monitoring of cancer. Small structures. 2020 Dec;1(3):2000063.HTML
88. Cescon DW, Bratman SV, Chan SM, Siu LL. Circulating tumor DNA and liquid biopsy in oncology. Nature Cancer. 2020.HTML
89. Hirahata T, ul Quraish R, Quraish AU, ul Quraish S, Naz M, Razzaq MA. Liquid biopsy: a distinctive approach to the diagnosis and prognosis of cancer. Cancer Informatics. 2022 Feb;21:11769351221076062.sagepub.com
90. Wu X, Li J, Gassa A, Buchner D, Alakus H, Dong Q, Ren N, Liu M, Odenthal M, Stippel D, Bruns C. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. International journal of biological sciences. 2020;16(9):1551.nih.gov
91. Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic—implementation issues and future challenges. Nature reviews Clinical oncology. 2021.ulb.ac.be
92. Hofman P. Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers. Cancer cytopathology. 2021.wiley.com
93. Russano M, Napolitano A, Ribelli G, Iuliani M, Simonetti S, Citarella F, Pantano F, Dell’Aquila E, Anesi C, Silvestris N, Argentiero A. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. Journal of Experimental & Clinical Cancer Research. 2020 Dec;39(1):13. biomedcentral.com
94. Heald B, Hampel H, Church J, Dudley B, Hall MJ, Mork ME, Singh A, Stoffel E, Stoll J, You YN, Yurgelun MB. Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis. Familial cancer. 2020 Jul;19:22339.nih.gov
95. Daca Alvarez M, Quintana I, Terradas M, Mur P, Balaguer F, Valle L. The inherited and familial component of earlyonset colorectal cancer. Cells. 2021 Mar 23;10(3):710.mdpi.com
96. Testa U, Castelli G, Pelosi E. Genetic alterations of metastatic colorectal cancer. Biomedicines. 2020.mdpi.com
97. Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, Ilyas M, Kaur A, Lalloo F, Latchford A, Rutter MD. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer genetics group (UKCGG). Gut. 2020 Mar 1;69(3):41144.bmj.com
98. Ahmed M. Colon cancer: a clinician's perspective in 2019. Gastroenterology research. 2020.nih.gov
99. Kastrinos F, Samadder NJ, Burt RW. Use of family history and genetic testing to determine risk of colorectal cancer. Gastroenterology. 2020.HTML
100. Yalchin M, Baker AM, Graham TA, Hart A. Predicting colorectal cancer occurrence in IBD. Cancers. 2021.mdpi.com
101. Done JZ, Fang SH. Youngonset colorectal cancer: A review. World journal of gastrointestinal oncology. 2021.nih.gov
102. Mao R, Krautscheid P, Graham RP, Ganguly A, Shankar S, Ferber M, Hegde M, ACMG Laboratory Quality Assurance Committee. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 2021 Oct 1;23(10):180717. sciencedirect.com
103. Rodríguez J, Avila J, Rolfo C, RuízPatiño A, Russo A, Ricaurte L, OrdóñezReyes C, Arrieta O, ZatarainBarrón ZL, Recondo G, Cardona AF. When tissue is an issue the liquid biopsy is nonissue: a review. Oncology and therapy. 2021 Jun;9:89110. springer.com
104. Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, ElRifai W, Bedognetti D, Batra SK, Haris M, Bhat AA. Liquid biopsy: A step closer to transform diagnosis, prognosis and future of cancer treatments. Molecular cancer. 2022 Mar 18;21(1):79. springer.com
105. Underwood JJ, Quadri RS, Kalva SP, Shah H, Sanjeevaiah AR, Beg MS, Sutphin PD. Liquid biopsy for cancer: review and implications for the radiologist. Radiology. 2020 Jan;294(1):517.rsna.org
106. Martins I, Ribeiro IP, Jorge J, Gonçalves AC, SarmentoRibeiro AB, Melo JB, Carreira IM. Liquid biopsies: applications for cancer diagnosis and monitoring. Genes. 2021 Feb 27;12(3):349.mdpi.com
107. Michela B. Liquid biopsy: a family of possible diagnostic tools. Diagnostics. 2021.mdpi.com
108. Alix‐Panabières C, Pantel K. Liquid biopsy: From discovery to clinical implementation. Molecular Oncology. 2021.nih.gov
109. Saito Y, Oka S, Kawamura T, Shimoda R, Sekiguchi M, Tamai N, Hotta K, Matsuda T, Misawa M, Tanaka S, Iriguchi Y. Colonoscopy screening and surveillance guidelines. Digestive Endoscopy. 2021 May;33(4):486519. HTML
110. GonzálezSuárez B, Pagés M, Araujo IK, Romero C, Rodríguez de Miguel C, Ayuso JR, Pozo À, VilaCasadesús M, Serradesanferm A, Ginès À, FernándezEsparrach G. Colon capsule endoscopy versus CT colonography in FITpositive colorectal cancer screening subjects: a prospective randomised trial—the VICOCA study. BMC medicine. 2020 Dec;18:11.springer.com
111. Jacobson BC, Calderwood AH. Measuring bowel preparation adequacy in colonoscopybased research: review of key considerations. Gastrointestinal Endoscopy. 2020.HTML
112. Selva A, Mosconi G, Cacitti S, Odone A, Pylkkanen L, Solà I, Torà N, Russo S, Cadum E, Deandrea S. Participants' satisfaction with colorectal cancer screening programs: A systematic review. Preventive Medicine. 2023 Sep 16:107706.HTML
113. Melson JE, Imperiale TF, Itzkowitz SH, Llor X, Kochman ML, Grady WM, Schoen RE, Burke CA, Shaukat A, Rabeneck L, Ladabaum U. AGA white paper: roadmap for the future of colorectal cancer screening in the United States. Clinical Gastroenterology and Hepatology. 2020 Nov 1;18(12):266778.cghjournal.org
114. Lansdorp‐Vogelaar I, Meester R, de Jonge L, Buron A, Haug U, Senore C. Risk‐stratified strategies in population screening for colorectal cancer. International Journal of Cancer. 2022 Feb 1;150(3):397405.wiley.com
115. Tonini V, Zanni M. Why is early detection of colon cancer still not possible in 2023?. World Journal of Gastroenterology. 2024.nih.gov
116. MaesCarballo M, GarcíaGarcía M, MartínDíaz M, EstradaLópez CR, IglesiasÁlvarez A, FiligranaValle CM, Khan KS, BuenoCavanillas A. A comprehensive systematic review of colorectal cancer screening clinical practices guidelines and consensus statements. British Journal of Cancer. 2023 Apr 6;128(6):94657.nature.com
117. Săftoiu A, Hassan C, Areia M, Bhutani MS, Bisschops R, Bories E, Cazacu IM, Dekker E, Deprez PH, Pereira SP, Senore C. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2020 Apr;52(04):293304.thiemeconnect.com
118. Makaroff KE, Shergill J, Lauzon M, Khalil C, Ahluwalia SC, Spiegel BM, Almario CV. Patient preferences for colorectal cancer screening tests in light of lowering the screening age to 45 years. Clinical Gastroenterology and Hepatology. 2023 Feb 1;21(2):52031.cghjournal.org
119. Elemento O, Leslie C, Lundin J, Tourassi G. Artificial intelligence in cancer research, diagnosis and therapy. Nature Reviews Cancer. 2021.osti.gov
120. Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer letters. 2020.sciencedirect.com
121. Dlamini Z, Francies FZ, Hull R, Marima R. Artificial intelligence (AI) and big data in cancer and precision oncology. Computational and structural biotechnology journal. 2020 Jan 1;18:230011. sciencedirect.com
122. Sufyan M, Shokat Z, Ashfaq UA. Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective. Computers in Biology and Medicine. 2023.HTML
123. Zhang C, Xu J, Tang R, Yang J, Wang W, Yu X, Shi S. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment. Journal of Hematology & Oncology. 2023 Nov 27;16(1):114.springer.com
124. Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial intelligence in cancer research and precision medicine. Cancer discovery. 2021.nih.gov
125. Manhas J, Gupta RK, Roy PP. A review on automated cancer detection in medical images using machine learning and deep learning based computational techniques: Challenges and opportunities. Archives of Computational Methods in Engineering. 2022 Aug;29(5):2893933.HTML
126. Saba T. Recent advancement in cancer detection using machine learning: Systematic survey of decades, comparisons and challenges. Journal of Infection and Public Health. 2020.sciencedirect.com
127. Dar RA, Rasool M, Assad A. Breast cancer detection using deep learning: Datasets, methods, and challenges ahead. Computers in biology and medicine. 2022.HTML
128. Carter SM, Rogers W, Win KT, Frazer H, Richards B, Houssami N. The ethical, legal and social implications of using artificial intelligence systems in breast cancer care. The Breast. 2020 Feb 1;49:2532. sciencedirect.com
129. Iqbal MJ, Javed Z, Sadia H, Qureshi IA, Irshad A, Ahmed R, Malik K, Raza S, Abbas A, Pezzani R, SharifiRad J. Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future. Cancer cell international. 2021 Dec;21(1):11.biomedcentral.com
130. Hunter B, Hindocha S, Lee RW. The role of artificial intelligence in early cancer diagnosis. Cancers. 2022.mdpi.com
131. Ahmad Z, Rahim S, Zubair M, AbdulGhafar J. Artificial intelligence (AI) in medicine, current applications and future role with special emphasis on its potential and promise in pathology: present and future …. Diagnostic pathology. 2021.springer.com
132. McCradden MD, Baba A, Saha A, Ahmad S, Boparai K, Fadaiefard P, Cusimano MD. Ethical concerns around use of artificial intelligence in health care research from the perspective of patients with meningioma, caregivers and health care providers: a qualitative study. Canadian Medical Association Open Access Journal. 2020 Jan 1;8(1):E905.cmajopen.ca
133. Lee D, Yoon SN. Application of artificial intelligencebased technologies in the healthcare industry: Opportunities and challenges. International Journal of Environmental Research and Public Health. 2021 Jan;18(1):271.mdpi.com
134. Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Communications. 2021 Nov;41(11):110015. wiley.com
135. Balasubramanian S, Shukla V, Sethi JS, Islam N, Saloum R. A readiness assessment framework for Blockchain adoption: A healthcare case study. Technological Forecasting and Social Change. 2021 Apr 1;165:120536.mdx.ac.uk
136. Schueller SM, Torous J. Scaling evidencebased treatments through digital mental health.. American Psychologist. 2020.apa.org
137. Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID19 pandemic: systematic review of early scientific literature. Journal of medical Internet research. 2020 Nov 6;22(11):e22280.jmir.org
138. Yaqoob I, Salah K, Jayaraman R, AlHammadi Y. Blockchain for healthcare data management: opportunities, challenges, and future recommendations. Neural Computing and Applications. 2021 Jan 7:16.HTML
139. James HM, Papoutsi C, Wherton J, Greenhalgh T, Shaw SE. Spread, scaleup, and sustainability of video consulting in health care: systematic review and synthesis guided by the NASSS framework. Journal of medical Internet research. 2021 Jan 26;23(1):e23775.jmir.org
140. Toufaily E, Zalan T, Dhaou SB. A framework of blockchain technology adoption: An investigation of challenges and expected value. Information & Management. 2021.HTML
141. Shankar V, Kalyanam K, Setia P, Golmohammadi A, Tirunillai S, Douglass T, Hennessey J, Bull JS, Waddoups R. How technology is changing retail. Journal of Retailing. 2021 Mar 1;97(1):1327.tamu.edu
142. King DK, Shoup JA, Raebel MA, Anderson CB, Wagner NM, Ritzwoller DP, Bender BG. Planning for implementation success using REAIM and CFIR frameworks: a qualitative study. Frontiers in public health. 2020 Mar 3;8:59.frontiersin.org
143. Li W, Yigitcanlar T, Erol I, Liu A. Motivations, barriers and risks of smart home adoption: From systematic literature review to conceptual framework. Energy Research & Social Science. 2021.qut.edu.au
144. Reinholz DL, Andrews TC. Change theory and theory of change: what’s the difference anyway?. International Journal of STEM Education. 2020 Dec;7(1):12.springeropen.com
145. Alwan, A. M., Rokaya, D., Kathayat, G., & Afshari, J. T. (2023). Oncoimmunity and therapeutic application of amygdalin: A review. Journal of Oral Biology and Craniofacial Research, 13(2), 155163.‏ sciencedirect.com